Chair, Nomenclature & Labeling Expert Committee
Career Highlights:
- University of Illinois Chicago College of Pharmacy: Professor and Executive Associate Dean for Faculty Affairs & Strategic Initiatives
- U.S. FDA Drug Safety and Risk Management (DSaRM) Advisory Committee: charter member and continued service as temporary advisory committee member and consultant
- American Society of Health-System Pharmacists (ASHP): Director of Scientific Affairs
Education:
- University of Texas, Ph.D., Pharmacy, major pharmaceutical policy
- University of Illinois, MPH, Health policy and administration
- University of Maryland, M.S., Institutional pharmacy programs
- University of Maryland Hospital and University of Maryland Hospital/Medical System: ASHP accredited pharmacy residency
- University of North Carolina, B.S., Pharmacy
- Georgetown University, Executive Certificate, Strategic Diversity & Inclusion Management
Awards, Recognition, Admissions:
- 2022 DIA (founded as Drug Information Association) Inspire Award – Excellence in Service, and Honorary Co-Chair
- Chair (former): DIA Regional Advisory Council for the Americas
- Fellow: American Pharmacists Association, Academy of Pharmaceutical Research & Science; DIA
- Co-recipient: American Association of Colleges of Pharmacy, Rufus A. Lyman Award
- Co-recipient: American Pharmacists Association Wiederholt Prize
A Few Favorite Professional Achievements:
- Co-recipient of USP group awards for Outstanding Contribution to the Standards as member of Expert Panel to Review Surveillance and Screening Technologies for Quality Assurance of Medicines; and Award for Outstanding Contribution to the Standards-setting Process presented to Nomenclature, Safety, and Labeling Expert Committee
- Outcomes of committee recommendations and decisions as FDA DSaRM member and consultant have positively affected millions of Americans with respect to drug product availability and safety
- Guest testimony before past FDA advisory committees prevented potential problems regarding proposed drug product brand names (e.g., comments prevented standard abbreviation “QD” from being incorporated in proprietary name)
